1 Department of Hematology and Oncology, Tufts Medical Center, Boston; Harvard T.H. Chan School of Public Health, Boston. Electronic address: ilana.schlam@tuftsmedicine.org.
2 Harvard T.H. Chan School of Public Health, Boston; Department of Biomedical Informatics, Harvard Medical School, Boston, USA.
3 Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Milan, Italy.
4 Department of Biomedical Informatics, Harvard Medical School, Boston, USA.
5 Department of Hematology and Oncology, Massachusetts General Hospital, Boston.
6 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA.